BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 23203280)

  • 1. Induction of apoptosis, G₀/G₁ phase arrest and microtubule disassembly in K562 leukemia cells by Mere15, a novel polypeptide from Meretrix meretrix Linnaeus.
    Liu M; Zhao X; Zhao J; Xiao L; Liu H; Wang C; Cheng L; Wu N; Lin X
    Mar Drugs; 2012 Nov; 10(11):2596-607. PubMed ID: 23203280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel polypeptide from Meretrix meretrix Linnaeus inhibits the growth of human lung adenocarcinoma.
    Wang C; Liu M; Cheng L; Wei J; Wu N; Zheng L; Lin X
    Exp Biol Med (Maywood); 2012 Apr; 237(4):442-50. PubMed ID: 22522344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mere15, a novel polypeptide from Meretrix meretrix, inhibits adhesion, migration and invasion of human lung cancer A549 cells via down-regulating MMPs.
    Wang H; Wei J; Wu N; Liu M; Wang C; Zhang Y; Wang F; Liu H; Lin X
    Pharm Biol; 2013 Feb; 51(2):145-51. PubMed ID: 23134156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mere15, a novel polypeptide from Meretrix meretrix, inhibits proliferation and metastasis of human non-small cell lung cancer cells through regulating the PI3K/Akt/mTOR signaling pathway.
    Xu B; Guo M; Ma L; Farooqi AA; Wang L; Qiao G; Liu M; Zuo L; Ye H; Lin X; Cao S
    Neoplasma; 2021 Nov; 68(6):1181-1189. PubMed ID: 34585588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Methoxybenzyl 5-Nitroacridone Derivative Effectively Triggers G1 Cell Cycle Arrest in Chronic Myelogenous Leukemia K562 Cells by Inhibiting CDK4/6-Mediated Phosphorylation of Rb.
    Zhang B; Zhang T; Zhang TY; Wang N; He S; Wu B; Jin HX
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Idelalisib induces G1 arrest and apoptosis in chronic myeloid leukemia K562 cells.
    Chen Y; Zhou Q; Zhang L; Wang R; Jin M; Qiu Y; Kong D
    Oncol Rep; 2016 Dec; 36(6):3643-3650. PubMed ID: 27748929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small Molecule TH-39 Potentially Targets Hec1/Nek2 Interaction and Exhibits Antitumor Efficacy in K562 Cells via G0/G1 Cell Cycle Arrest and Apoptosis Induction.
    Zhu Y; Wei W; Ye T; Liu Z; Liu L; Luo Y; Zhang L; Gao C; Wang N; Yu L
    Cell Physiol Biochem; 2016; 40(1-2):297-308. PubMed ID: 27855372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stellettin B induces apoptosis in human chronic myeloid leukemia cells via targeting PI3K and Stat5.
    Chen Y; Zhou Q; Zhang L; Zhong Y; Fan G; Zhang Z; Wang R; Jin M; Qiu Y; Kong D
    Oncotarget; 2017 Apr; 8(17):28906-28921. PubMed ID: 28423649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BJ-B11, a novel Hsp90 inhibitor, induces apoptosis in human chronic myeloid leukemia K562 cells through the mitochondria-dependent pathway.
    Ju HQ; Wang SX; Xiang YF; Liu Z; Liu JY; Chen ZP; Zeng FL; Xia M; Liu ZH; Xing GW; Wang SY; Wang YF
    Eur J Pharmacol; 2011 Sep; 666(1-3):26-34. PubMed ID: 21620825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel anti-tumor protein extracted from Meretrix meretrix Linnaeus induces cell death by increasing cell permeability and inhibiting tubulin polymerization.
    Ning X; Zhao J; Zhang Y; Cao S; Liu M; Ling P; Lin X
    Int J Oncol; 2009 Oct; 35(4):805-12. PubMed ID: 19724916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel tubulin polymerization inhibitor, MPT0B206, downregulates Bcr-Abl expression and induces apoptosis in imatinib-sensitive and imatinib-resistant CML cells.
    Chen CW; Lee YL; Liou JP; Liu YH; Liu CW; Chen TY; Huang HM
    Apoptosis; 2016 Sep; 21(9):1008-18. PubMed ID: 27344662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetylshikonin induces apoptosis of human leukemia cell line K562 by inducing S phase cell cycle arrest, modulating ROS accumulation, depleting Bcr-Abl and blocking NF-κB signaling.
    Hao G; Zhai J; Jiang H; Zhang Y; Wu M; Qiu Y; Fan C; Yu L; Bai S; Sun L; Yang Z
    Biomed Pharmacother; 2020 Feb; 122():109677. PubMed ID: 31810012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-leukemic effects of gallic acid on human leukemia K562 cells: downregulation of COX-2, inhibition of BCR/ABL kinase and NF-κB inactivation.
    Chandramohan Reddy T; Bharat Reddy D; Aparna A; Arunasree KM; Gupta G; Achari C; Reddy GV; Lakshmipathi V; Subramanyam A; Reddanna P
    Toxicol In Vitro; 2012 Apr; 26(3):396-405. PubMed ID: 22245431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-D gel electrophoresis-based proteomic analysis reveals that ormeloxifen induces G0-G1 growth arrest and ERK-mediated apoptosis in chronic myeloid leukemia cells K562.
    Pal P; Kanaujiya JK; Lochab S; Tripathi SB; Bhatt ML; Singh PK; Sanyal S; Trivedi AK
    Proteomics; 2011 Apr; 11(8):1517-29. PubMed ID: 21360677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chabamide induces cell cycle arrest and apoptosis by the Akt/MAPK pathway and inhibition of P-glycoprotein in K562/ADR cells.
    Ren J; Xu Y; Huang Q; Yang J; Yang M; Hu K; Wei K
    Anticancer Drugs; 2015 Jun; 26(5):498-507. PubMed ID: 25714087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zerumbone induces mitochondria-mediated apoptosis via increased calcium, generation of reactive oxygen species and upregulation of soluble histone H2AX in K562 chronic myelogenous leukemia cells.
    Rajan I; Jayasree PR; Kumar PR
    Tumour Biol; 2015 Nov; 36(11):8479-89. PubMed ID: 26026585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Benzo[B]Furans with Anti-Microtubule Activity Upregulate Expression of Apoptotic Genes and Arrest Leukemia Cells in G2/M Phase.
    Królewska-Golińska K; Cieślak MJ; Sobczak M; Dolot R; Radzikowska-Cieciura E; Napiórkowska M; Wybrańska I; Nawrot B
    Anticancer Agents Med Chem; 2019; 19(3):375-388. PubMed ID: 30465514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ZnO/CNT@Fe
    Yousefi AM; Safaroghli-Azar A; Fakhroueian Z; Bashash D
    Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):735-745. PubMed ID: 32272856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with imatinib mesylate against chronic myelogenous leukemia cell lines.
    Xin P; Li C; Zheng Y; Peng Q; Xiao H; Huang Y; Zhu X
    Drug Des Devel Ther; 2017; 11():1115-1126. PubMed ID: 28435223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.
    Zhang GS; Liu DS; Dai CW; Li RJ
    Am J Hematol; 2006 Apr; 81(4):242-55. PubMed ID: 16550520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.